BIONTECH SE SPON ADS EACH REP 1 ORD SHS
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

86.740

-1.350 (-1.53%)
Range - - -   (-%)
Open -
Previous Close 88.090
Bid Price 116.800
Bid Volume 12
Ask Price 116.990
Ask Volume 8
Volume 438,083
Value -
Remark
Delayed prices. Updated at 26 Apr 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis